Literature DB >> 11111041

Characterization of the mouse Smad1 gene and its expression pattern in adult mouse tissues.

S Huang1, K C Flanders, A B Roberts.   

Abstract

Smad1 belongs to a family of receptor-activated proteins which mediate signals from TGF-beta superfamily ligands, including TGF-beta and BMPs. Although much is known about the biochemistry of Smad1 signal transduction, the role of Smad1 in vivo is still unclear. Here we present the first description of the genomic structure of the mouse Smad1 gene and the characterization of its expression pattern in adult mouse tissues by immunohistochemistry. The Smad1 gene contains 7 exons and spans >42 kb of genomic DNA. Its coding region is contained within 6 exons and all introns, except intron 1, follow the GT/AG rule. Immunohistochemical analysis shows that Smad1 is widely expressed in adult mouse tissues, with a varying degree of nuclear localization in different cell types, suggesting a regulated function for this protein. This study assigns all of the exon-intron boundaries of the mouse Smad1 gene and provides the basis for assessing the functional significance of this gene using targeted gene manipulation in the mouse.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11111041     DOI: 10.1016/s0378-1119(00)00396-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  7 in total

1.  In vivo convergence of BMP and MAPK signaling pathways: impact of differential Smad1 phosphorylation on development and homeostasis.

Authors:  Josée Aubin; Alice Davy; Philippe Soriano
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

2.  Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca2+ entry in glomerular mesangial cells.

Authors:  Peiwen Wu; Yuezhong Ren; Yuhong Ma; Yanxia Wang; Hui Jiang; Sarika Chaudhari; Mark E Davis; Jonathan E Zuckerman; Rong Ma
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-15

3.  Identification and characterization of functional Smad8 and Smad4 homologues from Echinococcus granulosus.

Authors:  Chuanshan Zhang; Limin Wang; Hui Wang; Hongwei Pu; Le Yang; Jing Li; Junhua Wang; Guodong Lü; Xiaomei Lu; Wenbao Zhang; Dominique A Vuitton; Hao Wen; Renyong Lin
Journal:  Parasitol Res       Date:  2014-07-20       Impact factor: 2.289

4.  Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy.

Authors:  Tatsuya Tominaga; Hideharu Abe; Otoya Ueda; Chisato Goto; Kunihiko Nakahara; Taichi Murakami; Takeshi Matsubara; Akira Mima; Kojiro Nagai; Toshikazu Araoka; Seiji Kishi; Naoshi Fukushima; Kou-ichi Jishage; Toshio Doi
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

5.  Cloning and promoter activity of rat Smad1 5'-flanking region in rat hepatic stellate cells.

Authors:  Yu Sun; Jianghong Fan; Hong Shen; Ping Li; Peter Cattini; Yuewen Gong
Journal:  Mol Cell Biochem       Date:  2007-05-26       Impact factor: 3.396

6.  Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.

Authors:  Qiao Li; Lie Feng; Jiaying Li; Qianqian Chen
Journal:  Endocrine       Date:  2013-08-13       Impact factor: 3.633

7.  Conditional Deletion of Smad1 Ameliorates Glomerular Injury in Progressive Glomerulonephritis.

Authors:  Makoto Araki; Takeshi Matsubara; Hideharu Abe; Kazuo Torikoshi; Akira Mima; Noriyuki Iehara; Atsushi Fukatsu; Toru Kita; Hidenori Arai; Toshio Doi
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.